For the first time, we demonstrate that the Akt/NF-κB pathways may be involved in the expression of these molecules in HTNV-infected HUVECs, and cardamonin may serve as a potential, beneficial agent for HFRS therapy. This evidence concerns the gene AKT1 and hemorrhagic fever with renal syndrome.